Literature DB >> 12590574

Global structure and dynamics of human apolipoprotein CII in complex with micelles: evidence for increased mobility of the helix involved in the activation of lipoprotein lipase.

J Zdunek1, G V Martinez, J Schleucher, P O Lycksell, Y Yin, S Nilsson, Y Shen, G Olivecrona, S Wijmenga.   

Abstract

Apolipoprotein CII (apoCII), a surface constituent of plasma lipoproteins, is the activator for lipoprotein lipase (LPL) and is therefore central for lipid transport in blood. The three-dimensional structure of (13)C-, (15)N-enriched human full-length apoCII in complex with sodium dodecyl sulfate (SDS) micelles is reported. In addition to the structure determination, (15)N-relaxation measurements have been performed at two magnetic fields to characterize the dynamics of the backbone of apoCII in the complex. The relaxation data also provided global structural constraints, viz. the orientation of helices in the complex. In addition, global constraints were derived from the fact that apoCII helices are attached to the surface of the SDS micelle and that the hydrophobic moments of each helix faces the interior of the micelle. These three categories of global constraints, together with the local classical NMR constraints, were sufficient to define the 3D structure of the apoCII-SDS micelle complex. To our knowledge, this presents the first example in which the global structure of a protein-SDS micelle complex has been determined. The C-terminal helix of apoCII is known to be responsible for the activation of LPL. This helix is distinguished from the other helices by a higher degree of internal motion on the nanosecond time scale as shown by the relaxation data. The overall structure and the internal dynamics, combined with previous mutation data, give important clues toward a possible mechanism for the activation of LPL by apoCII.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590574     DOI: 10.1021/bi0267184

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.

Authors:  Marcelo J A Amar; Toshihiro Sakurai; Akiko Sakurai-Ikuta; Denis Sviridov; Lita Freeman; Lusana Ahsan; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2014-11-13       Impact factor: 4.030

2.  Detection of nano-second internal motion and determination of overall tumbling times independent of the time scale of internal motion in proteins from NMR relaxation data.

Authors:  Göran Larsson; Gary Martinez; Jürgen Schleucher; Sybren S Wijmenga
Journal:  J Biomol NMR       Date:  2003-12       Impact factor: 2.835

3.  Surface rheology and adsorption kinetics reveal the relative amphiphilicity, interfacial activity, and stability of human exchangeable apolipoproteins.

Authors:  Victor Martin Bolanos-Garcia; Anne Renault; Sylvie Beaufils
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

Review 4.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

5.  A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II.

Authors:  Nathan L Meyers; Mikael Larsson; Gunilla Olivecrona; Donald M Small
Journal:  J Biol Chem       Date:  2015-05-29       Impact factor: 5.157

6.  Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.

Authors:  Toshihiro Sakurai; Akiko Sakurai; Boris L Vaisman; Marcelo J Amar; Chengyu Liu; Scott M Gordon; Steven K Drake; Milton Pryor; Maureen L Sampson; Ling Yang; Lita A Freeman; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

7.  Effects of oxidation, pH and lipids on amyloidogenic peptide structure: implications for fibril formation?

Authors:  Andrew Hung; Michael D W Griffin; Geoffrey J Howlett; Irene Yarovsky
Journal:  Eur Biophys J       Date:  2008-09-04       Impact factor: 1.733

8.  Apolipoprotein C-II Adopts Distinct Structures in Complex with Micellar and Submicellar Forms of the Amyloid-Inhibiting Lipid-Mimetic Dodecylphosphocholine.

Authors:  Timothy M Ryan; Michael D W Griffin; Duncan J McGillivray; Robert B Knott; Kathleen Wood; Colin L Masters; Nigel Kirby; Cyril C Curtain
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

9.  Site-directed mutagenesis of apolipoprotein CII to probe the role of its secondary structure for activation of lipoprotein lipase.

Authors:  Yan Shen; Aivar Lookene; Liyang Zhang; Gunilla Olivecrona
Journal:  J Biol Chem       Date:  2009-12-30       Impact factor: 5.157

Review 10.  Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.

Authors:  Anna Wolska; Richard L Dunbar; Lita A Freeman; Masako Ueda; Marcelo J Amar; Denis O Sviridov; Alan T Remaley
Journal:  Atherosclerosis       Date:  2017-10-20       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.